| scholarly article | Q13442814 |
| P356 | DOI | 10.1084/JEM.171.6.1943 |
| P953 | full work available at URL | http://rupress.org/jem/article-pdf/171/6/1943/1100397/1943.pdf |
| https://europepmc.org/articles/PMC2187969 | ||
| https://europepmc.org/articles/PMC2187969?pdf=render | ||
| P932 | PMC publication ID | 2187969 |
| P698 | PubMed publication ID | 1693655 |
| P5875 | ResearchGate publication ID | 277398326 |
| P2093 | author name string | L. Hood | |
| O. Kanagawa | |||
| G. Osman | |||
| D. M. Zaller | |||
| P2860 | cites work | Murine T-cell receptor mutants with deletions of beta-chain variable region genes | Q35588981 |
| Transfer of allergic encephalomyelitis in rats by means of lymph node cells | Q36264745 | ||
| Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes | Q36349092 | ||
| Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein | Q36355775 | ||
| Cellular events in the induction of experimental allergic encephalomyelitis in rats | Q36359869 | ||
| In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis | Q36380180 | ||
| The role of the T-cell receptor in thymocyte maturation: effects in vivo of anti-receptor antibody | Q37407953 | ||
| Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy | Q39272381 | ||
| Autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy | Q39272903 | ||
| Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen | Q39528741 | ||
| Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides | Q43794379 | ||
| Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis | Q45351794 | ||
| Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. | Q45997264 | ||
| Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse | Q46496912 | ||
| Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention | Q46499427 | ||
| Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis | Q46597614 | ||
| Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis | Q46633710 | ||
| Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. | Q46793479 | ||
| Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse | Q48349566 | ||
| Autoimmune encephalomyelitis: simultaneous identification of T and B cells in the target organ | Q49133706 | ||
| The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis | Q53438445 | ||
| T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. | Q53897545 | ||
| Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice | Q53910981 | ||
| Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant | Q53929508 | ||
| Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen. | Q53959426 | ||
| T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis | Q59049925 | ||
| Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker | Q67274504 | ||
| Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes | Q72644608 | ||
| Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells | Q72823021 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| immunology | Q101929 | ||
| P304 | page(s) | 1943-1955 | |
| P577 | publication date | 1990-06-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies | |
| P478 | volume | 171 |
| Q70722241 | A comparative study of T-cell receptor V beta usage in non-obese diabetic (NOD) and I-E transgenic NOD mice |
| Q36229747 | A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis |
| Q72921070 | A possible role of two hydrophobic amino acids in antigen recognition by synovial T cells in rheumatoid arthritis |
| Q41426185 | A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen |
| Q40380711 | Advances in selective immunosuppression. |
| Q67464153 | Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy |
| Q67906611 | Analysis of T cell receptor V alpha and V beta gene usage in synovia of patients with rheumatoid arthritis |
| Q72617993 | Analysis of T cell receptor V beta regions expressed by rheumatoid synovial T lymphocytes |
| Q40511583 | Animal models of autoimmune endocrine disease and their uses in developing new methods of intervention |
| Q41023588 | Anti-T-cell receptor therapy in murine experimental systemic lupus erythematosus. |
| Q36635307 | Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease |
| Q35173096 | Antigen-Specific Tolerance as a Therapy for Experimental Autoimmune Encephalomyelitis |
| Q67546044 | Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-V beta 8 antibodies |
| Q33897559 | Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay |
| Q39827387 | Bacterial pyrogenic exotoxins as superantigens |
| Q74460605 | Both B and gammadelta TCR(+) lymphocytes regulate alphabeta TCR(+) lymphocytes involved in superantigen specific responses |
| Q72082611 | Bromodeoxyuridine and light treatment deletes effector but not suppressor cells of autoimmune encephalomyelitis |
| Q44547142 | Characterization of experimental allergic encephalomyelitis-susceptible, Biozzi AB/H (H-2dq1) mice which express H-2Anod: analysis of T-cell receptor expression and the detection of a deletion ligand encoded by Mtv-7. |
| Q48188089 | Characterization of rat encephalitogenic T cells bearing non-V beta 8 T cell receptors |
| Q41859484 | Characterization of the T cell receptor repertoire causing collagen arthritis in mice |
| Q36230864 | Cross-species transplantation tolerance: rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor V beta in chimeras tolerant to xenogeneic antigens (mouse + rat----mouse). |
| Q41232477 | Derivation of T-cell receptor alpha-chain double expresser lines from normal murine mature T cells |
| Q41577465 | Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein. |
| Q30988818 | Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes |
| Q35173105 | EAE: a model for immune intervention with synthetic peptides |
| Q72788288 | Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice |
| Q39706642 | Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis? |
| Q36363728 | Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. |
| Q41293419 | Experimental immunotherapies for multiple sclerosis. |
| Q34234228 | Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis |
| Q35868117 | How T cells recognise antigen: implications for lung diseases |
| Q40437100 | Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis |
| Q41722148 | Immunological treatment of autoimmune diseases. |
| Q41094924 | Immunopathogenesis and immunotherapy of psoriasis. |
| Q77922185 | Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview |
| Q40392025 | Immunotherapeutic Strategies Directed at the Trimolecular Complex |
| Q67863087 | Immunotherapy in autoimmune diseases |
| Q74099005 | Induction of a heterogeneous TCR repertoire in (PL/JXSJL/J)F1 mice by myelin basic protein peptide Ac1-11 and its analog Ac1-11[4A] |
| Q73614033 | Inhibition of experimental allergic encephalomyelitis with an antibody that recognizes a novel antigen expressed on lymphocytes, endothelial cells, and microglia |
| Q34159098 | Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor |
| Q36725418 | Interaction of T Lymphocytes with Cerebral Endothelial Cells in vitro |
| Q36635102 | Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule |
| Q37644134 | Junctional region sequences of T-cell receptor beta-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens |
| Q37611185 | Limitations in plasticity of the T-cell receptor repertoire |
| Q37638293 | Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis |
| Q34224070 | Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. |
| Q73722382 | Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis |
| Q48003593 | Molecular basis of type II collagen autoimmune ear diseases |
| Q34599773 | Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis |
| Q70888086 | Multiple sclerosis |
| Q41710811 | Pathogenesis of neuroimmunologic diseases. Experimental models |
| Q43480050 | Positive selection of Tcrb-V10b+ T cells |
| Q39879273 | Predominant T-cell receptor Vbeta usage of intraepithelial lymphocytes during the immune response to enteric reovirus infection |
| Q67693900 | Protection against experimental autoimmune encephalomyelitis requires both CD4+ T suppressor cells and myelin basic protein-primed B cells |
| Q52043808 | Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice. |
| Q36627545 | Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor V beta gene products. |
| Q36230664 | Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment |
| Q71941621 | Restricted T cell receptor repertoire for acetylcholine receptor in murine myasthenia gravis |
| Q41902251 | Specific Immunoregulation of the Induction and Effector Stages of Relapsing EAE via Neuroantigen-Specific Tolerance Induction |
| Q46201877 | Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen |
| Q48345912 | Successful prevention of retrocochlear hearing loss in murine experimental allergic encephalomyelitis with T cell receptor Vbeta8-specific antibody |
| Q48821019 | Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats |
| Q71696220 | Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2 |
| Q36230424 | Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins |
| Q36364627 | T cell and non-T cell compartments can independently determine resistance to Leishmania major |
| Q42494191 | T cell receptor V-gene usage in oral lichen planus; increased frequency of T cell receptors expressing V alpha 2 and V beta 3. |
| Q36359571 | T cell targeted immunotherapy for autoimmune disease |
| Q40541780 | T-cell antigen receptors in rheumatoid arthritis |
| Q40838105 | T-cell receptor genes in autoimmunity |
| Q52859680 | T-cell receptor β usage by 35 different antigen-specific T-cell clones restricted by HLA-Dw4 or -Dw14.1 |
| Q43977151 | TCR usage and cytokine expression in peripheral blood and BAL T cells |
| Q36665881 | The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease |
| Q36364563 | The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. |
| Q40465752 | The T-cell receptor in multiple sclerosis. |
| Q37598723 | The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal |
| Q73899120 | The characterization of testicular cell (TC)-specific T-cell clones induced by intratesticular Listeria monocytogenes infection: TC-specific T cells with atypical cytokine profile transfer orchitis |
| Q41506877 | The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates |
| Q40519644 | The pharmacology of T cell apoptosis |
| Q40403377 | The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis |
| Q67905091 | Therapy against murine collagen-induced arthritis with T cell receptor Vβ-specific antibodies |
| Q33713319 | Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. |
| Q36380528 | Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide |
| Q36747079 | Transgenic mouse model for central nervous system demyelination |
| Q36410815 | Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). |
| Q40465721 | T‐Cell Receptor Use in Early Rheumatoid Arthritisa |
| Q43643623 | Unique T-cell receptor junctional sequences found in multiple sclerosis and T-cells mediating experimental allergic encephalomyelitis |
| Q37085898 | Vaccines for multiple sclerosis: progress to date |
| Q52859810 | Variable gene usage of T cell receptor γ- and δ-chain transcripts expressed in synovia and peripheral blood of patients with rheumatoid arthritis |
Search more.